Insights & news

Court of Justice of European Union Rules on Updating of Documentation of Medicinal Products Subject to Parallel Import Licence

  • 13/10/2020
  • Articles

Attached is a note discussing the judgment of the Court of Justice of the European Union (CJEU) in kohlpharma II. The judgment deals with updates to the documentation of medicinal products subject to a parallel import licence in situations where the marketing authorisation of the reference product in the Member State of importation has expired. It appears that the CJEU attaches a greater weight to the free movement principles than to the protection of public health.


Key contacts

Related practice areas

Related insights

Sign up for updates

Subscribe to our updates

Please select the practice areas you are interested in: *